CIRCULOGENE THERANOSTICS

CirculoGene is a biotechnology company that specializes in the fields of cfDNA, liquid biopsy, tumor monitoring, laboratory testing, and molecular diagnostics. its proprietary laboratory-developed test for cfDNA, cRNA, and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis from one standard tube of blood in one week, enabling more accurate data to help clinicians and their patients choose targeted therapies, monitor efficacy and monitor for recurrence. The company was founded in 2015 and is headquartered in Alabama, United States.